The involvement of the calcium messenger system in the control of steroidogenesis in the rat and bovine adrenal cortex has been studied extensively.
INTRODUCTION
Recent studies have shown that in both rat and bovine adrenal zona glomerulosa cells the increase in aldosterone secretion seen in response to adrenocorticotrophin (ACTH), potassium and angiotensin II is mediated by both the cyclic AMP (cAMP) and the phosphatidyl-inositol second messenger system (Capponi, Lang, Rossier et al. 1986; Tait, Chu, Hyatt et al. 1986 ).
Angiotensin II increases intracellular inositol trisphosphate (IP3) and diacylglycerol (DAG) concentrations, leading to a release of calcium from intracellular stores and the activation of protein kinase C (Enyedi, Buki, Musci & Spät, 1985; Baila, Baukal, Guillemette et al. 1986; Lang & Vallotton, 1987; Rossier, Krause, Lew et al. 1987) . Potassium, in contrast, has no effect on phosphatidylinositide metabolism but may increase cAMP (Kojima, Kojima & Rasmussen, 1985) . Cyclic AMP is considered to be the major second messenger for ACTH (Fujita, Aguilera & Catt, 1979) , although there are reports of ACTH-induced increases in IP3 production and thus intracellular calcium at low doses (Farese, Rosic, Babischkin et al. 1986 ). In addition, both potassium and ACTH increase the intracellular calcium concentration by increasing calcium influx across the plasma membrane (Baila, Hunyady & Spät, 1982; Hausdorff, Aguilera & Catt, 1986; Kojima & Ogata, 1986) . In the rat zona glomerulosa, the increases in calcium concentration and activation of protein kinase C have been shown to have a specific effect on the secretion of latepathway products (18-hydroxycorticosterone and aldosterone) (Vinson, Laird, Whitehouse & Hinson, 1989) .
Steroid secretion by inner zone cells is under the control of ACTH. As in the zona glomerulosa this control is considered to be mediated primarily by cAMP, although again it has been suggested that IP3 may be involved at low doses of ACTH (Farese et al. 1986 (Fig. 3) . The inhibition was significant for all doses of ACTH used (10 fmol/1-1 pmol/1).
Potassium-stimulated steroid secretion was also inhibited by verapamil (Fig. 4) . In this case, inhibi¬ tion of aldosterone and corticosterone was seen only at high concentrations of potassium (10-7 and 13*1 mmol K + /l), while potassium-stimulated corti¬ sol production was inhibited at all doses. Verapamil also inhibited desacetyl-ot-MSH-stimulated aldo¬ sterone, corticosterone and cortisol production (Fig. 5) (Fujita et al. 1979 ) although, at low doses of ACTH, increased IP3 has also been observed (Farese et al. 1986 causing increases in cAMP, IP3 and DAG (Capponi et al. 1986; Tait et al. 1986 ). The increase in aldosterone secretion brought about by the calcium ionophore A23187 (Fig. 1) suggests that, as in other species (Williams, McDougall, Tait & Tait, 1981) , calcium is involved in the control of aldosterone secretion by human adrenocortical zona glomerulosa cells. Results ob¬ tained with the calcium channel blocker verapamil also support this. In the collagenase-dispersed human adrenocortical cell preparation, ACTH and desacetyl-a-MSH are major stimulants, whereas angiotensin II has little effect (Henville et al. 1989) . Verapamil inhibited the increase in aldosterone secretion seen with ACTH and desacetyl-a-MSH and also with high potassium (Figs. 3-5 ). Of these stimulants, ACTH and also potassium, according to some authors (Kojima et al. 1985; Tait et al. 1986) but not others (Fujita et al. 1979) , have a primary action on adenylate cyclase, thus increasing cAMP production. In addition, both bring about an increase in cytosolic calcium by their action on the voltage-gated calcium channels in the plasma mem¬ brane (Baila et al. 1982; Hausdorff et al. 1986 ). Although in the rat a-MSH is thought also to exert its primary action through adenylate cyclase activa¬ tion (Tait et al. 1986) , the mechanism by which desacetyl-a-MSH brings about an increase in aldosterone secretion in human adrenocortical cells is as yet unknown. The results in this paper suggest that, as with the other stimulants, calcium mobiliza¬ tion is involved.
A23187 also caused a dose-dependent increase in corticosterone production (Fig. 1) (Figs. 3-5 ). This contrasts with results obtained in the rat adrenal zona glomerulosa, in which A23187 increased aldosterone and verapamil inhibited ACTH-and potassium-stimulated aldo¬ sterone production, but neither had any significant effect on corticosterone , suggesting that calcium mobilization specifically affects late-pathway events. In the present experi¬ ments, changes in corticosterone secretion are consistent with the view that, in the human zona glomerulosa, calcium mobilization primarily affects an early point in the biosynthetic pathway.
The results obtained with the phorbol ester TPA, (Kojima, Lippes, Kojima & Rasmussen, 1983; Kojima, Kojima, Kreutter & Rasmussen, 1984) , while others have been unable to obtain a similar increase in steroid production in the rat (Spät, 1988) . We have previously reported that TPA increased aldosterone production by the intact rat zona glomerulosa but not by collagenasedispersed cells ). (Podesta, Milani, Steffen & Neher, 1980) . More recently, TPA and A23187 have been shown to increase cortisol production in the bovine adrenal cortex (Culty, Vilgrain & Chambaz, 1984; Finn, Stehle, Ricci & Hofmann, 1988; Kenyon et al. 1988 ).
It has been demonstrated that angiotensin II and possibly also ACTH exert their effects on steroido¬ genesis in the bovine zona fasciculata by stimulating phosphatidylinositol turnover (Hadjian, Culty & Chambaz, 1984; Finn et al. 1988 In conclusion, the results in this paper show that protein kinase C activation and calcium mobilization do have a role in the control of steroid production by the human adrenal cortex. However, in contrast to the rat but in agreement with data from the bovine adrenal, these effects appear to be non-specific, affecting both zona glomerulosa and inner zone steroid production.
